AppLovin stock: strong profits, 83% EBITDA margins, 45% FCF, buybacks, and CTV growth—why there’s 67% upside. See here for more on APP stock.

Microglia, the brain's resident immune cells, deploy cytokines, chemokines, complement proteins, and phosphatidylserine ...

A new review argues that mitochondrial dysfunction is the central mechanism linking metabolic stress, inflammation, and nerve ...

Bret Bostwick, a physician-scientist and venture partner at Breyer Capital, argues that the hardest problem in CNS drug development is not finding ...

The human brain reduces neural circuits during the process of growthThe human brain, reduces the connections between nerve ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Axon Markets has appointed Panagiotis Karamanis as its new Head of Asia, tasking the business development veteran to scale ...

AXON is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of AXON shares has increased $5.77 since the market last closed. This is a 1.39 ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

James Reece’s war isn’t over! Chris Pratt is leading the charge again in the second season of The Terminal List, the Prime Video thriller that first premiered on July 1, 2022. The series comes from ...